Clinical Trial Update: Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Efpeglenatide to Dulaglutide in adults with Type 2 Diabetes mellitus inadequately controlled on metformin; study terminated with posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dulaglutide (dulaglutide)
• efpeglenatide (efpeglenatide)

Snippet

Sponsor: Sanofi | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: TERMINATED | Results posted: 2021-11-01